Christopher Tipton, MD
Orthopaedic Surgery · Vicksburg, MSNPI 1801282223
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (52.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 75.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2020 at $24,576 and has fallen 99.2% since, to $204 in 2025.
Across 100 payments — averaging $381.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$29K
- Gemini Mountain Medical, LLC$5K
- Zimmer Biomet$4K
- Smith+Nephew$435
- Stryker$373
- Orthalign Inc$108
- plus $349 from 9 others
What the payments were for
- Grants$20,00052%
- Travel & lodging$4,51012%
- Food & beverage$2,7397%
- Education$10,85628%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 44 | $28,610 |
| Gemini Mountain Medical, LLC | 2 | $4,556 |
| Zimmer Biomet | 26 | $3,675 |
| Smith+Nephew | 9 | $435 |
| Stryker | 5 | $373 |
| Orthalign Inc | 1 | $108 |
| Pylant Medical | 1 | $104 |
| Bioventus LLC | 4 | $77 |
| KCI USA, Inc. | 2 | $36 |
| Pacira Pharmaceuticals Incorporated | 1 | $33 |
| Paragon 28, Inc. | 1 | $30 |
| Organogenesis Inc. | 1 | $21 |
| Solventum Corporation | 1 | $19 |
| Sonex Health, Inc. | 1 | $15 |
| Vertex | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,105 in reported general payments places this provider in the 85th percentile of 170 orthopaedic surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 61 | $2,054 |
| Celecoxib | 60 | $962 |
| Clindamycin Phosphate | 35 | $756 |
| Meloxicam | 256 | $667 |
| Oxycodone Hcl | 115 | $643 |
| Ibuprofen | 139 | $615 |
| Tramadol Hcl | 135 | $417 |
| Mupirocin | 49 | $405 |
| Naproxen | 40 | $328 |
| Methylprednisolone | 38 | $264 |
| Cephalexin | 34 | $183 |
| Cyclobenzaprine Hcl | 25 | $162 |
| Gabapentin | 27 | $148 |
| Clindamycin Hcl | 17 | $122 |
| Ondansetron Hcl | 21 | $96 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Vicksburg
- Matthew GravesJackson$1.2M
- George van OstenTupelo$322K
- Edward HobgoodJackson$267K
- Hanna MitiasNew Albany$249K
- Stephen SouthworthTupelo$160K
- Jamey BurrowJackson$130K
- Jeff AlmandJackson$109K
- Spencer MontgomeryJackson$90K
- Larry FieldJackson$88K
- Joseph CoxGulfport$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.